Last reviewed · How we verify
Sodium lauryl sulfate 0.1%
Sodium lauryl sulfate 0.1% is a Small molecule drug developed by Pfizer. It is currently in Phase 1 development.
At a glance
| Generic name | Sodium lauryl sulfate 0.1% |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% Bemotrizinol (PHASE2)
- A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations (PHASE4)
- Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins (PHASE4)
- Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion (PHASE1)
- PCM1-JAK2 in Therapy Related Neoplasms
- Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects (PHASE4)
- A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects (PHASE1)
- 21 Day Cumulative Skin Irritation of RUT058-60 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sodium lauryl sulfate 0.1% CI brief — competitive landscape report
- Sodium lauryl sulfate 0.1% updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Sodium lauryl sulfate 0.1%
What is Sodium lauryl sulfate 0.1%?
Sodium lauryl sulfate 0.1% is a Small molecule drug developed by Pfizer.
Who makes Sodium lauryl sulfate 0.1%?
Sodium lauryl sulfate 0.1% is developed by Pfizer (see full Pfizer pipeline at /company/pfizer).
What development phase is Sodium lauryl sulfate 0.1% in?
Sodium lauryl sulfate 0.1% is in Phase 1.
Related
- Manufacturer: Pfizer — full pipeline
- Compare: Sodium lauryl sulfate 0.1% vs similar drugs
- Pricing: Sodium lauryl sulfate 0.1% cost, discount & access